Prostate Cancer : News

Healthline's Premium Tools

Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace

UroToday.com - A study in the August 1, 2008 edition of the Journal of Clinical Oncology by Dr.

Source:MediLexicon
Date:August 25, 2008

Asia Pacific News.Net Monday 25th August, 2008 Survival after cancer is improving significantly in Australia, especially among the better-off groups in the population, according to a report.

Source:Asia Pacific News .Net
Date:August 25, 2008

While the pets afflicted were different in age, breed and residence, they all possessed a common trait.

Source:Sunherald.com
Date:August 25, 2008

WASHINGTON: Vitamin D, which the body makes when exposed to sunlight, may help prevent multiple sclerosis , suggests a new study.

Source:The Hindu
Date:August 24, 2008

Gina Palmese shouldered her heavy golf bag and trudged back to the Highland Golf Club clubhouse in the sweltering heat Friday afternoon after completing 18 holes in the 10th annual Prostate Cancer Research Golf ...

Source:Recorder Times
Date:August 24, 2008

Greg Conko laments an increasingly cautious Food & Drug Administration. The FDA approved just 16 new drugs last year, and is on pace to approve only 18 this year.

Source:The Volokh Conspiracy
Date:August 24, 2008

Dennis Locke was among about 70 men who had a free digital exam today, a procedure that some find embarrassing, during the Third Annual Prostate Health Forum at Southside High.

Source:The Greenville News
Date:August 23, 2008

Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today > BOTHELL, WA, Aug.

Source:Canada NewsWire
Date:August 23, 2008

OGX-011 is currently completing five Phase 2 clinical studies in prostate, lung and breast cancer, and is designed to inhibit the production of a specific protein, clusterin, associated with treatment ...

Source:Rehab Management
Date:August 22, 2008
Advertisement
Back to Top